Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Atriva Therapeutics
511
Atriva Therapeutics
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Therapeutics
Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.
Suggest edits
Founded
2015
Raised
$8.6M
Follow us
Companies in the same industry
Myonexus Therapeutics, Inc.
SyntheX
Nutcracker Therapeutics
Vast Therapeutics
Ventus Therapeutics
Topix Pharmaceuticals, Inc.
Nuo Therapeutics
IMMT - Institute of Metagenomics...
Trobix Bio
PeptiMimesis
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$8,600,000
Debt financing - 2020
High-Tech Gründerfonds
Meneldor
Undisclosed amount
Venture capital (Series A) - 2019
High-Tech Gründerfonds (HTGF)
Meneldor
Team Size
1–10
Employees
I work here
Location
Germany
Headquarters
Explore Germany
$8,600,000
Debt financing
FinSMEs
Atriva Therapeutics Closes €8.6M Oversubscribed Convertible Loan
Venture capital (Series A)
FinSMEs
Atriva Therapeutics Raises Initial Series A Funding
Seed fund
atriva-therapeutics
,
High-Tech Gründerfonds
Atriva Therapeutics GmbH - Atriva receives seed financing to develop its next generation influenza therapeutic
